Antipsychotic therapy and short-term serious events in older adults with dementia
…, T Gomes, SS Gill, GM Anderson, M Melo… - Archives of internal …, 2008 - jamanetwork.com
Background Antipsychotic therapy is widely used to treat behavioral problems in older adults
with dementia. Cohort studies evaluating the safety of antipsychotic therapy generally focus …
with dementia. Cohort studies evaluating the safety of antipsychotic therapy generally focus …
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada
…, HR Thiessen-Philbrook, L Ping, M Melo… - …, 2008 - journals.lww.com
Background. Knowledge of any harm associated with living kidney donation guides informed
consent and living donor follow-up. Risk estimates in the literature are variable, and most …
consent and living donor follow-up. Risk estimates in the literature are variable, and most …
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures
V Demers, M Melo, C Jackevicius, J Cox… - Cmaj, 2008 - Can Med Assoc
Background: Reimbursement for outpatient prescription drugs is not mandated by the
Canada Health Act or any other federal legislation. Provincial governments independently …
Canada Health Act or any other federal legislation. Provincial governments independently …
[HTML][HTML] Cardiovascular outcomes after a change in prescription policy for clopidogrel
CA Jackevicius, JV Tu, V Demers, M Melo… - … England Journal of …, 2008 - Mass Medical Soc
Background Drug-reimbursement policies may have an adverse effect on patient outcomes
if they interfere with timely access to efficacious medications for acute medical conditions. …
if they interfere with timely access to efficacious medications for acute medical conditions. …
Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?
JD Douketis, M Melo, CM Bell, MM Mamdani - The American journal of …, 2007 - Elsevier
PURPOSE: Recent observations in patients with atrial fibrillation who are receiving warfarin
suggest that concomitant treatment with a 3-hydroxy-3-methylglutaryl coenzyme A reductase …
suggest that concomitant treatment with a 3-hydroxy-3-methylglutaryl coenzyme A reductase …
[HTML][HTML] Validity of vascular trauma codes at major trauma centres
…, TF Lindsay, KW Johnston, M Melo… - Canadian Journal of …, 2013 - ncbi.nlm.nih.gov
Background The use of administrative databases in vascular injury research has been
increasing, but the validity of the diagnosis codes used in this research is uncertain. We assessed …
increasing, but the validity of the diagnosis codes used in this research is uncertain. We assessed …
[HTML][HTML] Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study
M Al-Omran, MM Mamdani, TF Lindsay, M Melo… - Journal of vascular …, 2008 - Elsevier
BACKGROUND: Current evidence suggests that statin use plays an important role in
improving adverse cardiovascular outcomes in patients with atherosclerosis. However, limited …
improving adverse cardiovascular outcomes in patients with atherosclerosis. However, limited …
Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials
…, K Shah, R Iyengar, R Nisenbaum, M Melo… - Journal of the American …, 2013 - jacc.org
Objectives : This study assessed whether the results of major, potentially practice-altering
cardiovascular trials were influenced by the authors' self-declared financial conflicts of interest (…
cardiovascular trials were influenced by the authors' self-declared financial conflicts of interest (…
Challenges to evidence-based prescribing in clinical practice
…, A Ching, B Golden, M Melo… - Annals of …, 2008 - journals.sagepub.com
Although there appears to be widespread support of evidence-based medicine as a basis
for rational prescribing, the challenges to it are signilicant and often justified. A multitude of …
for rational prescribing, the challenges to it are signilicant and often justified. A multitude of …
Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort …
S Verma, MM Mamdani, M Al-Omran, M Melo… - Journal of the American …, 2007 - Elsevier
Inhibitors of the renin-angiotensin system remain a cornerstone of cardiovascular
pharmacotherapy. Although angiotensin converting enzyme inhibitors (ACEIs) have been …
pharmacotherapy. Although angiotensin converting enzyme inhibitors (ACEIs) have been …